Skip to content

13F-HR filed by Crestline Management, L.P.

Crestline Management, L.P. filed this 13F-HR for the quarter ended 2025-06-30, filed 2025-08-14, with 3 holding rows worth $62,562,865.

Accession
0001315863-25-000627
Filed
2025-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2025

A combination report, 3 entries on the cover page, a total value of $62,562,865 stated on the cover page (in dollars after the unit check, H1), rows summing to $62,562,865 with VALUE read as dollars as filed, 13F file number 028-14917. The quarter's positions are built on this report. The resolved quarter.

Other managers

  • reports for this filerSummitTX Capital, L.P. 028-14917

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
DENALI THERAPEUTICS INC COM24823R105Stock3,860,732$54,011,641dollars as filed
SANA BIOTECHNOLOGY INC799566104COM2,420,937$6,609,158dollars as filed
8X8 INC282914100COMMON STOCK990,580$1,942,066dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001315863-25-000627this filing2025-08-14acceptance time not in the bulk data set